Insights On Partnering

1. From Legacy To Lifeline: Advancing Rare Disease Care 6/13/2025

   Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.

2. eCOA Standards And KPIs To Include In Your Next RFI 3/9/2026

   Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

3. How Smarter Financial Strategies Improve Trial Performance 3/10/2025

   CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.

4. Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy 9/25/2025

   Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.

5. How Real-World Data On Site Costs Accelerates Clinical Trial Success 10/23/2025

   Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

6. Delivering Specialist Neurology Support 4/17/2025

   Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

7. Strategic Considerations For Oncology Trials In A Competitive Landscape 5/14/2025

   By combining strategic foresight with hands-on support, the right partner accelerates oncology trial delivery and broadens access to promising therapies.

8. Rethinking Trial Access Through Trust-Driven Design And Local Collaboration 5/19/2026

   Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

9. Price Matters - Why Dash Believes In Transparency 5/15/2026

   Opaque pricing slows decisions and erodes trust. Transparency clarifies cost drivers, improves budgeting, enables confident sourcing, and strengthens long-term R&D partnerships.

10. Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch 8/7/2025

    Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.